Testing effectiveness (Phase 2)UnknownNCT04377334
What this trial is testing
Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)
Who this might be right for
ARDSCOVID-19
University Hospital Tuebingen 40